Coloplast (CPH:COLO B) said today it inked a definitive agreement to purchase urological device supplier Comfort Medical for $160 million. Comfort Medical is a direct-to-consumer dealer of durable medical equipment including catheters and ostomy supplies, and Coloplast said the acquisition “is a continuation” of its ambition to bring innovative products and services to the US market. […]
Urology
Neotract touts coverage win for UroLift prostate device
NeoTract said today it won coverage for its Urolift system from Medicare Administrative Contractor First Coast Service Options. The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside tissue from the enlarged prostate. First Coast Service Options covers […]
Augmenix scores reimbursement code for SpaceOar
Augmenix said today it won a category 1 current procedural terminology reimbursement code from the American Medical Association for periprostatic implantation of biodegradable material, covering its flagship SpaceOAR device. The SpaceOar is designed to separate the prostate from the rectal wall during radiation treatment for prostate cancer, Augmenix said. The device is delivered through a small needle […]
Boston Scientific launches Dakota nitinol kidney stone retrieval device
Boston Scientific (NYSE:BSX) said today it launched its Dakota nitinol retrieval device designed for kidney stone retrieval in the U.S. and Europe. The Dakota stone retrieval device is designed to work with kidney stones of multiple sizes, ranging from 1 mm to 10 mm, Marlborough, Mass.-based Boston Scientific. “The Dakota Retrieval Device with OpenSure Handle offers […]
Profound Medical looks to raise $15m
Profound Medical (TSX:PRN) said today that it pulled in a $13.2 million (C$17.4 million) funding round that includes an over-allotment option that could bring in another $2 million (C$2.6 million). Led by GMP Securities, the syndicate of underwriters agreed to buy 15.82 million shares at about 84¢ (C$1.10) apiece, with an optional over-allotment of 2.373 million shares for the 30 […]
NeoTract touts reimbursement win for UroLift
NeoTract today touted a reimbursement win from Geisinger Health Plan and EmblemHealth that will allow coverage for procedures using its UroLift system for patients with benign prostatic hyperplasia. The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside […]
Audax deals Laborie Medical to Patricia Industries
Private equity player Audax Group said today it sold Laborie Medical Technologies to Investor AB subsidiary Patricia Industries for an undisclosed amount. Toronto-based Laborie Medical Tech develops and manufactures urological, pelvic health and gastrointestinal medical devices used for diagnosis and treatment of urinary incontinence and other urological and GI conditions, Audax Medical said. Laborie acquired the pelvic muscle […]
Report: Coloplast looks to expand in Minnesota
Coloplast (CPH:COLO B) is looking to expand its worker base in Minnesota, according to a new report from the Twin Cities Business Mag. The company, which acquired the urology business mentor Minnesota in 2006, has its North American headquarters in Minneapolis, Minn. with 310 employees in the area. Coloplast is looking to add an additional 3,000 staff […]
SRS Medical launches Spanner prostate device study
SRS Medical Systems said today it enrolled the 1st patients in an FDA investigational device exemption study as it seeks to expand the indications for its Spanner temporary prostatic stent. The Spanner device consists of a pair of anchors and a silicone tube and is designed to reduce resistance in the bladder neck and prostatic urethra without […]
Medi-Tate wins strategic investment from Canada’s Laborie Medical Technologies
Laborie Medical Technologies said it took out a stake in Israel’s Medi-Tate, which is developing devices to treat enlarged prostates, for an unspecified amount. Toronto-based Laborie, which is owned by private equity company Audax Group, in October 2013 acquired the pelvic muscle rehabilitation business of UroMed Technology, also for an undisclosed amount. Akiva, Israel-based Medi-Tate developed a minimally invasive […]
NeoTract logs reimbursement wins for UroLift prostate treatment
NeoTract said today that it logged several reimbursement wins for its UroLift treatment for enlarged prostates, including a Medicare contractor and at least 7 independent insurers. The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside tissue from the […]